Clinical Trial | By Collet JP, Silvain J, ARCTIC investigators.
BACKGROUND - Optimum duration of dual antiplatelet treatment (DAPT) after coronary stenting remains uncertain, with an unknown efficacy to safety ratio of extended treatment leading to discrepancies between international guidelines and clinical practice. We assessed whether DAPT continuation beyond 1 year after coronary stenting is beneficial. METHODS - This analysis was a planned extension of...
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
Clinical Trial | By Mauri L, Kereiakes DJ, DAPT Study Investigators.
Clinical Trial | By Helft G, Steg PG, OPTImal DUAL Antiplatelet Therapy Trial Investigators.
Clinical Trial | By Feres F, Costa RA, OPTIMIZE Trial Investigators.
Clinical Trial | By Hong SJ, Shin DH, IVUS-XPL Investigators.